HIV infection no related factors influence on neuropsychological performance of seropositives;Influencia de factores no relacionados con la infección en el rendimiento neuropsicológico de seropositivos al VIH

Revista de Neurologia

Volumn 35, Issue 5, 2002, Pages 474-480

  Vazquez Justo E ^a   Rodríguez Álvarez, Marina ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

AIDS; Cognitive reserve; Depressed mood; Drugs abuse; Neuropsychological assessment

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; COGNITION; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; DRUG ABUSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; MOOD; NEUROPSYCHOLOGY; PSYCHOLOGIC ASSESSMENT; REVIEW; SEROLOGY; VIRUS INFECTION;

EID: 0036771273     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.3505.2001454     Document Type: Review

References (105)

1. Brew B, Rosenblum M, Price RW. AIDS dementia complex and primary HIV brain infection. J Neuroimmunol 1988; 10: 1330-40.
2. Everall IP, Luthbert PJ, Lantos PL. Neuronal loss in frontal cortex in HIV infection. Lancet 1991; 337: 1119-21.
3. Martin A. HIV cognition, and the basal ganglia. In Grant I, Martin A, eds. Neuropsychology of HIV infection. New York: Oxford University Press; 1994. p. 234-59.
4. Wilkins JW, Robertson KR, van der Horst C, Robertson WT, Fryer JG, Hall CD. The importance of confounding factors in the evaluation of neuropsychological changes in patients infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1990; 3: 938-42.
5. Marder K, Liu X, Stern Y, Dooneief G, Bell K, Schofield P, et al. Neurologic sings and symptoms in a cohort of homosexual men followed for 4.5 years. Neurology 1995; 45: 261-7.
6. Selnes OA, Galai N, Bacellar H, Miller EN, Becker JT, Wesch J, et al. Cognitive performance after progression to AIDS: a longitudinal study from the Multicenter AIDS Cohort Study. Neurology 1995; 45: 267-75.
7. Selnes OA, Galai N, McArthur JC, Cohn S, Royal III W, Esposito D, et al. HIV infection and cognition in intravenous drug users: long term follow up. Neurology 1997; 48: 223-30.
8. Vázquez-Justo E, Rodríguez-Álvarez M, Rodríguez-Salgado D. Funcionamiento neuropsicológico en drogodependientes VIH/SIDA inmunodeprimidos: importancia de las fase de la infección y del consumo de drogas. Revista Española de Drogodependencias 2000; 25: 263-78.
9. Farinpour R, Martin EM, Seindenberg M, Pitrak DL, Pursell KJ, Mullane KM, et al. Verbal working memory in HIV-seropositive drug users. J Intern Neuropsychol Soc 2000; 6: 548-55.
10. Grassi MP, Perin C, Borella M, Mangoni A. Assessment of cognitive function in asymptomatic HIV-positive. Eur Neurol 1999; 42: 225-9.
11. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wallace MR, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome HIV Neurobehavioral Research Center Group. Ann Neurol 1997; 42: 679-88.
12. Stankoff B, Calvez V, Suárez S, Bassi P, Rosenblum O, Conquy L, et al. Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairment. Eur J Neurol 1999; 6: 669-75.
13. Claypoole KH, Townes BD, Collier AC, Marra C, Longstreth WT, Cohen W, et al. Cognitive risk factors and neuropsychological performance in HIV infection. Int J Neurosci 1993; 70: 13-27.
14. Hestad K, Updike M, Selnes OA, Royal W. Cognitive sequelae of repeated head injury in a population of intravenous drug users. Scand J Psychol 1995; 36: 246-55.
15. Baldeweg T, Catalan J, Pugh K, Gruzelier J, Lovett E, Scurlock H, et al. Neuropsychological changes associated with psychiatric symptoms in HIV infected individuals without AIDS. Biol Psychiatry 1997; 41: 474-87.
16. Bix BC, Glosser G, Holmes W, Ballas C, Meritz M, Hutelmyer C, et al. Relationship between psychiatric disease and neuropsychological impairment in HIV seropositive individuals. J Intern Neuropsychol Soc 1995; 1: 581-8.
17. Rodríguez D. Afectación neuropsicológica temprana asociada a la infección por VIH en drogodependientes. Universidad de Santiago de Compostela; 2001.
18. Rodríguez D, Rodríguez M. Vulnerabilidad neuropsicológica de los drogodependientes a la infección por VIH-1. Revista Española de Drogodependencias 1997; 22: 203-18.
19. Satz P, Morgenstern H, Miller EN, Selnes OA, McArthur JC, Cohen BA, et al. Low education as a possible risk factor for cognitive abnormalities in HIV-1: findings from the multicenter AIDS cohort study (MACS). J Acquir Immune Defic Syndr 1993; 6: 503-11.
20. Levin HS, Benton AL, Grossman RG. Neurobehavioral consequences of closed head injury. New York: Oxford University Press; 1982.
21. Marder K, Stern Y, Malouf R, Tang M, Bell K, Dooneief G, et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Arch Neurol 1992; 49: 1169-75.
22. Bornstein RA, Podraza AM, Para MF, Whitacre CC, Fass RJ, Rice RR, et al. Effect of minor head injury on neuropsychological performance in asymptomatic HIV-1 infection. Neuropsychology 1993; 7: 228-34.
23. Atkinson JH, Grant I, Kennedy CJ, Richman DD, Spector SA, Mccutchan JA. Prevalence of psychiatric disorders among men infected with human immunodeficiency virus. Arch Gen Psychiatry 1988; 45: 859-64.
24. Boceralli A, Dilley JW, Shore MD. Neuropsychiatric aspects of AIDS. Dementia complex: a report on a clinical series. Neurotoxicology 1988; 9: 381-90.
25. Brown GR, Rundell JR, McManis SE, Kendall SN, Zachary R, Temoshok L. Prevalence of psychiatric disorders in early stages of HIV infection. Psychosom Med 1992; 54: 588-601.
26. Chuang HT, Jason GW, Pajurkova EM, Gill MJ. Psychiatric morbidity in patients with HIV infection. Can J Psychiatry 1992; 37: 109-15.
27. Grant I, Atkinson JH. The evolution of neurobehavioral complications of HIV infection (Editorial). Psychol Med 1990; 20: 747-54.
28. Beresford TP, Blow FC, Hall RCW. AIDS encephalitis mimicking alcohol dementia and depression. Biol Psychiatry 1986; 21: 394-7.
29. Carne CA, Adler MW. Neurological manifestations of human immunodeficiency virus infection. Br Med J 1986; 293: 462-3.
30. Detmer WM, Lu FG. Neuropsychiatric complications of AIDS: a literature review. Int J Psychiatry Med 1986; 16: 21-9.
31. Pérez-Stable EJ, Miranda J, Muñoz RF. Depression in medical outpatients: underrecognition and misdiagnosis. Arch Gen Psychiatry 1990; 150: 1083-8.
32. Schmitt FA, Dickson LR, Browwers P. Neuropsychological response to antirretroviral therapy in HIV infection. In Grant I, Martin A, eds. Neuropsychology of HIV Infection. New York: Oxford University Press; 1994. p. 276-4.
33. Drugs that cause psychiatric symptoms. Med Lett 1989; 31: 113-8.
34. Grant I, Olshen RA, Atkinson JH, Henton RK, Nelson J, McCutchan JA, et al. Depressed mood does not explain neuropsychological deficits in HIV-infected persons. Neuropsychology 1993; 7: 53-61.
35. Hinkin CH, van Gorp WG, Satz P, Weisman JD, Thommes J, Buckingham S. Depressed mood and its relationship to neuropsychological test performance in HIV-1 seropositive individuals. J Clin Exp Neuropsychol 1992; 14: 289-97.
36. Mapou RL, Law WA, Martin A, Kampen D, Salazar AM, Rundell JR. Neuropsychological performance, mood, and complains of cognitive and motor difficulties in individuals infected with the human immunodeficiency virus. J Neuropsychiatry Clin Neurosci 1993; 5: 86-93.
37. Riccio M, Pugh K, Jadresic D, Burges A, Thompson C, Wilson B, et al. Neuropsychiatric aspects of HIV-1 infection in gay men: controlled investigation of psychiatric, neuropsychological and neurological status. J Psychosom Res 1993; 37: 819-30.
38. Maj M. Psychiatric aspects of HIV-1 infection and AIDS. Psychol Med 1990; 20: 547-63.
39. Van Gorp WG, Hinkin C, Satz P, Miller EN, Weisman J, Holston S, et al. Subtypes of HIV-related neuropsychological functioning: a cluster analysis approach. Neurology 1993; 7: 62-72.
40. Bornstein RA, Pace P, Rosenberger P, Nasrallah HA, Para MF, Whitacre CC, et al. Depression and neuropsychological performance in asymptomatic HIV infection. Am J Psychiatry 1993; 150: 922-7.
41. Perdices M, Dumbar N, Grunseit A, Hall W, Cooper, DA. Anxiety, depression and HIV related symptomatology across the spectrum of HIV disease. Aust N Z J Psychiatry 1992; 26: 560-6.
42. Perry SW. HIV-related depression. Res Publ Assoc Res Nerv Ment Dis 1994; 72: 223-38.
43. Johnson RT, McArthur JC. AIDS and the brain. Trends Neurosci 1986; 9: 91-4.
44. Price RW, Navia BA, Cho ES. AIDS encephalopathy. Neurol Clin 1986; 4: 285-301.
45. Kaleschtein AD, Hinkin CH, van Gorp WG, Castellón SA, Satz P. Depression predicts procedural but not episodic memory in HIV-1 infection. J Clin Exp Neuropsychol 1998; 20: 529-35.
46. Richardson MA, Satz PF, Myer HF, Miller EN, Bing EG, Fawzy FI, et al. Effects of depressed mood versus clinical depression on neuropsychological test performance among African American men impacted by HIV/AIDS. J Clin Exp Neuropsychol 1999; 21: 769-83.
47. Martin A, Heyes MP, Salazar AM., Kampen DL, Williams J, Law WA, et al. Progressive slowing of reaction time and increasing cerebrospinal fluid concentration of quinolic acid in HIV-infected individuals. J Neuropsychiatry Clin Neurosci 1992; 4: 270-9.
48. Pace PL, Rosenberger P, Nasrallah HA, Bornstein RA. Depression and neuropsychological performance in symptomatic HIV infection. J Clin Exp Neuropsychol 1993; 15: 95.
49. Perkins DO, Stern RA, Golden RN, Murphy C, Naflolowitz D, Evans DL. Mood disorders in HIV infection: prevalence and risk factors in a nonepicenter of the AIDS epidemic. Am J Psychiatry 1994; 151: 233-6.
50. Drebing CE, van Gorp WG, Hinkin C, Miller EN, Satz P, Kim DS, et al. Confounding factor in the measurement of depression in HIV. J Pers Assess 1994; 62: 68-83.
51. Poutiainen E. Cognitive deficits and emotional disorders in HIV- 1 infected individuals. Acta Psychiatr Scand 1995; 92: 429-35.
52. Law WA, Martin A, Salazar AM, Mapou RL. Symptoms of depression in HIV infected individuals: etiological considerations. Neuropsychiatry, Neuropsychol Behav Neurol 1993; 6: 181-6.
53. Fell M, Newman S, Herns M, Durrance P, Manji H, Connolly S, et al. Mood and psychiatric disturbance in HIV and AIDS: changes over time. Br J Psychiatry 1993; 162: 604-10.
54. Gorman JM, Kertzner R, Cooper T, Goetz RR, Lagomasino I, Novachenko H, et al. Glucocorticoid level and neuropsychiatric symptoms in homosexual men with HIV infection. Am J Psychiatry 1991; 148: 41-5.
55. Pearson J, Richter RW. Neuropathological effects of opiate addiction. In Richter RW, ed. Medical aspects of drug abuse. Hagerstown: Harper & Row; 1975. p. 274-6.
56. Royal W. Drug overdose and withdrawal. In Johnson RT, ed. Current therapy in neurologic disease. Philadelphia: BC Becker; 1990. p. 313-6.
57. Donahoe RM, Nicholson JKA, Madden JJ. Coordinate and independent effects of heroin, cocaine, and alcohol abuse on T-cell E-rosette formation and antigenic marker expression. Clin Immunol Immunopathol 1986; 41: 254-64.
58. Nahas GG, Suciu-Foca N, Armand JP, Morishima A. Inhibition of cellular mediated immunity in marijuana smokers. Science 1974; 183: 419-20.
59. Sapira JD. The narcotic addict as a medical patient. Am J Med 1968; 45: 555-89.
60. Grant I, Adams KM, Carlin AS, Rennick PM, Judd LL, Schooff K. The collaborative neuropsychological study of polydrug users. Arch Gen Psychiatry 1978; 35: 1063-74.
61. Reed RJ, Grant J. The long-term neurobehavioral consequences of substance abuse: conceptual and methodological challenges for future research. NIDA Res Monogr 1990; 101: 10-56.
62. Stern Y. Neuropsychological assessment of seropositive intravenous drug users. In Grant I, Martin A, eds. Neuropsychology of HIV infection. New York: Oxford University Press.; 1994. p. 220-33.
63. Grant I, Judd LL. Neuropsychological and EEG disturbances in polidrug users. Am J Psychiatry 1976; 133: 1039-42.
64. Meek PS, Clark HW, Solana VL. Neurocognitive impairment: the unrecognized component of dual diagnosis in substance abuse treatment. J Psychoactive Drugs 1989; 21: 153-60.
65. Rodríguez M. Memoria visoconstructiva en politoxicómanos. Revista de la Asociación Española de Neuropsiquiatría 1992; 42: 184-7.
66. Rodríguez M. Dependencia a opiáceos y aprendizaje de palabras. Actas Luso Esp Neurol Psiquiatr Cienc Afines 1993; 21: 161-4.
67. Sweeney JA, Meisel L, Walsh VL, Castrovinci D. Assessment of cognitive functioning in opiate addicts. J Clin Psychol 1989; 45: 346-51.
68. Marder K, Liu X, Stern Y, Malouf R, Dooneief G, Bell K, et al. Risk of human immunodeficiency virus type 1-related neurologic disease in a cohort of intravenous drug users. Arch Neurol 1995; 52: 1174-82.
69. Royal W, Updike M, Selnes OA, Proctor TV, Nance-Sproson L, Solomon L, et al. HIV-1 infection and nervous system abnormalities among a cohort of intravenous drug users. Neurology 1991; 41: 1905-10.
70. Selnes OA, Jacobson L, Machado AM, Becker JT, Wesch J, Miller EN, et al. Normative data for a brief neuropsychological screening battery. Multicenter AIDS Cohort study. Percept Mot Skills 1991; 73: 539-50.
71. Bono G, Mouri M, Sinforiani E, Barbarini G, Minoli L, Fea M. Longitudinal neuropsychological evaluation of HIV infected intravenous drug users. Addiction 1996; 91: 263-8.
72. Cappa SE, Truong TM, Vangi D, Vignolo LA. The neuropsychological consequences of HIV infection in drug addicts. Ital J Neurol Sci 1992; 13: 465-8.
73. Concha M, Graham NMH, Muñoz A, Vlahov D, Royal W, Updike M, et al. Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity. Am J Epidemiol 1992; 136: 1338-48.
74. Egan VG, Crawford JR, Brettle RP, Goodwin GM. The Edinburgh cohort of HIV-positive drug users: current intellectual function is impaired, but not due to early AIDS dementia complex. AIDS 1990; 4: 651-6.
75. Egan V, Brettle RP, Goodwin GM. The Edinburgh cohort of HIV-positive drug users: pattern of cognitive impairment in relation to progression of disease. Br J Psychiatry 1992; 161: 522-31.
76. Grassi MP, Perin C, Clerici F, Zocchetti C, Cargnel A, Mangoni A. Neuropsychological performance in HIV-1-infected drug abusers. Acta Neurol Scand 1993; 88: 119-22.
77. Grassi MP, Clerici F, Perin C, Zochetti C, Borella M, Cargnel A, et al. HIV infection and drug use: influence on cognitive function. AIDS 1995; 9: 165-70.
78. Hestad K, Aukrust P, Ellertsen B, Klove H, Wilberg K. Neuropsychological deficits in HIV-1 seropositive and seronegative intravenous drug users. J Clin Exp Neuropsychol 1993; 15: 732-42.
79. Marder K, Stern Y, Malouf R, Tang M, Bell K, Dooneief G, et al. Neurologic and neuropsychological manifestations of human immunodeficiency virus infection in intravenous drug users without acquired immunodeficiency syndrome. Arch Neurol 1992; 49: 1169-75.
80. Pakesch G, Loimer N, Grunberger J, Pfersmann D, Linzmayer L, Mayerhofer S. Neuropsychological findings and psychiatric symptoms in HIV-1 infected and noninfected drug users. Psychiatry Res 1992; 41: 163-77.
81. Selnes OA, McArthur JC, Royal W, Updike M, Nance-Sproson L, Concha M, et al. HIV-1 infection and intravenous drug use: Longitudinal neuropsychological evaluation of asymptomatic subjects. Neurology 1992; 42: 1924-30.
82. Sola J, Caro F, Royo J. Estudio neuropsicológico del deterioro cognitivo-motor asociado a la infección por VIH en pacientes adictos a drogas por vía parental. [www.cfnavarra.es/salud/anales/textos/suple6/suple17.html; 1998].
83. Avants SK, Margolin A, McMahon TJ, Kosten TR. Association between self-report of cognitive impairment, HIV status, and cocaine use in a sample of cocaine-dependent methadone-maintained patients. Addict Behav 1997; 22: 599-611.
84. Bartok JA, Martin EM, Pitrak DL, Novak RM, Pursell KJ, Mullane KM, et al. Working memory deficits in HIV-seropositive drug users. Journal of International Neuropsychol Soc 1997; 3: 451-6.
85. Del Pesce M, Franciolini B, Censori B, Bartolini, M, Ancarani F, Petrelli E, et al. Cognitive behavior in asymptomatic (CDC stage II and III) HIV-seropositive intravenous drug users. Ital J Neurol Sci 1993; 17: 619-25.
86. Heaton RK, Grant I, Butters N, White DA, Kirson DA, Atkinson JH, et al. The HNRC 500-neuropsychology of HIV infection at different disease stages. J Intern Neuropsychol Soc 1995; 1: 231-51.
87. McKegney FP, O'Downd MA, Feiner C, Selwyn PA, Druker E, Friedland GA. Prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients. AIDS 1990; 4: 565-9.
88. Silberstein CH, McKegney FP, O'Dowd MA, Selwyn PA, Schoenbaum EE, Druker E, et al. A prospective longitudinal of neuropsychological and psychosocial factors in asymptomatic individuals al risk of HTLV-III/LAV infection in a methadone program: Preliminary findings. Int J Neurosci 1987; 32: 669-76.
89. Silberstein CH, O'Dowd MA, Chartock P, Schoenbaum EE, Friedland G, Hartel D, et al. A prospective four year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients. Gen Hosp Psychiatry 1993; 15: 351-9.
90. Sopelana P, Debora M, López-Calvo S, García-Álvarez JC, Polo C. Alteraciones neuropsicológicas en drogodependientes infectados por el virus de la inmunodeficiencia humana. Archiv Neurobiol 1992; 55: 228-34.
91. Starace F, Baldassarre C, Biancolilli V, Fea M, Serpelloni G, Bartoli L, et al. Early neuropsychological impairment in HIV-seropositive intravenous drug users: evidence from the Italian Multicentre Neuropsychological HIV study. Acta Psychiatr Scand 1998; 97: 132-8.
92. Wellman MC. Neuropsychological impairment among intravenous drug users in pre-AIDS stages of HIV infection. Int J Neurosci 1992; 64: 183-94.
93. Wilkie FL, Eisdorfer C, Morgan R, Loewenstein DA, Szapocznik J. Cognition in early human immunodeficiency virus infection. Arch Neurol 1990; 47: 433-40.
94. Ardila A, Roselli M, Strumwasser S. Neuropsychological deficits in chronic cocaine abusers. Int J Neurosci 1991; 57: 73-9.
95. Carnero-Pardo C. Educación, demencia y reserva cerebral. Rev Neurol 2000; 31: 584-92.
96. Sánchez JL, Rodríguez M, Carro J. Influence of cognitive reserve on neuropsychological functioning in Alzheimer's disease type sporadic in subjects of Spanish nationality. Neuropsychiatry Neuropsychol Behav Neurol 2002; 15: 113-22.
97. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 1993; 7: 273-95.
98. Bonaiuto S, Roca WA, Lippi A, Luciani P, Turtú F, Cavarzeran F, et al. Impact of education and occupation on prevalence of Alzheimer's disease (AD) and multi-infarct dementia (MID) in Appignano, Macerata Province, Italy. Neurology 1990; 40 (Suppl 1): S346.
99. Fratiglioni L, Grut M, Forsell Y, Vütanen M, Grafström M, Holmen K, et al. Prevalence of Alzheimer's disease and other dementias in a elderly urban population: relationship with age, sex, and education. Neurology 1991; 41: 1886-92.
100. Gorelick PB, Brody J, Cohen D, Freels S, Levy P, Dollear W, et al. Risk factors for dementia associated with multiple cerebral infarcts: a case-control analysis in predominantly Aftican-American hospital-based patients. Arch Neurol 1993; 50: 714-20.
101. Ott A, Breteler MMB, van Harskamp F, Clauss JJ, van der Cammen TJM, Grobbee DE, et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam Study. Br J Med 1995; 310: 970-3.
102. Glatt SL, Hubble JP, Lyons K, Troster AJ, Hassanein RE, Koller WC. Risk factors for dementia in Parkinson's disease: effect of education. Neuroepidemiology 1996; 15: 20-5.
103. Pereda M, Ayuso-Mateos JL, Gómez del Barrio A, Echevarría S, Farinas MC, García-Palomo D, et al. Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS. Psychol Med 2000; 30: 205-17.
104. Stern RA, Silva SG, Chaisson N, Evans DL. Influence of cognitive reserve on neuropsychological functioning in asymptomatic human immunodeficiency virus-1 infection. Arch Neurol 1996; 53: 148-53.
105. Bornstein RA. Methodological and conceptual issues in the study of cognitive change in HIV infection. In Grant I, Martin A, eds. Neuropsychology of HIV infection. New York: Oxford University Press; 1994. p. 146-60.